OTC & Nutraceuticals India

India Smoking Cessation Products Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

India Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $70.8 Mn Placeholder estimate
Estimate 2025 $76.5 Mn 1.7% of the global market
Projected 2034 $154.3 Mn 101.6% Adds $77.7 Mn over 9 forecast years
CAGR 2025–2034 8.1% Faster than 12% of 82 OTC & Nutraceuticals markets here
Key players 5
  • India is 1.74% of the global market.
  • In APAC, the largest is China at $401.6 Mn.
  • Fastest growing: India (this report) at 8.1% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$77.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smoking Cessation Products Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $70.8 Mn — —
2025 (base) $76.5 Mn +$5.7 Mn —
2026 (forecast) $82.7 Mn +$6.2 Mn +8.1%
2027 (forecast) $89.4 Mn +$6.7 Mn +16.9%
2028 (forecast) $96.7 Mn +$7.2 Mn +26.3%
2029 (forecast) $104.5 Mn +$7.8 Mn +36.6%
2030 (forecast) $113.0 Mn +$8.5 Mn +47.6%
2031 (forecast) $122.1 Mn +$9.2 Mn +59.6%
2032 (forecast) $132.0 Mn +$9.9 Mn +72.5%
2033 (forecast) $142.7 Mn +$10.7 Mn +86.5%
2034 (forecast) $154.3 Mn +$11.6 Mn +101.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

India Smoking Cessation Products Market Analysis at a glance
Market size, 2025$76.5 Mn placeholder estimate
Forecast, 2034$154.3 Mn placeholder estimate
Growth (CAGR), 2025–20348.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, form and distribution channel (see all)
Key playersHaleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all)
Regulator in IndiaCDSCO and FSSAISource: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.Source: Food Safety and Standards Authority of India. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Smoking Cessation Products Market Analysis Executive Summary

Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.

Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).

Bar chart: India Smoking Cessation Products market size, 2024–2034, placeholder estimates. $70.8 Mn in 2024, $76.5 Mn in 2025 and $154.3 Mn in 2034, 8.1% CAGR.
India Smoking Cessation Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Smoking Cessation Products Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.

Competitive Landscape for Smoking Cessation Products Market in India

The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smoking Cessation Products Market in India

Smoking Cessation Products in India: rules and health figures

New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.⁠[1] Health supplements and nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI).⁠[2] Smoking (adults): 22.6% of adults in 2024, the latest World Bank figure for India.⁠[3]

[1] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[2] Food Safety and Standards Authority of India. Checked 14 Nov 2026.

[3] World Bank Open Data, Smoking (adults) (% of adults). Retrieved 16 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in India.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smoking Cessation Products in context

India compared

  • Smoking (adults): 22.6% of adults (2024). World: 20.3% of adults (2024). 6th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 10th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 11th highest of the 15 countries we cover in APAC.[3]

[1] World Bank Open Data, Smoking (adults) (% of adults). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smoking Cessation Products market in India?
Placeholder estimate: about $76.5 Mn in 2025, rising to about $154.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smoking Cessation Products market in India growing?
Placeholder estimate: about 8.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smoking Cessation Products market report cover?
The report splits the market by product (Nicotine Replacement Therapy, Prescription Drugs, Digital Quit Programs), form (Patches, Gum and Lozenges, Sprays and Inhalers, Tablets) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Smoking Cessation Products market?
Key players include Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc and Cipla Inc..
What is driving the Smoking Cessation Products market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
Who regulates Smoking Cessation Products in India?
New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India. Health supplements and nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI). Source: Central Drugs Standard Control Organisation. Checked 14 Nov 2026. Source: Food Safety and Standards Authority of India. Checked 14 Nov 2026.
What does World Bank report for India?
Smoking (adults): 22.6% of adults in 2024, the latest World Bank figure. Source: World Bank Open Data, Smoking (adults) (% of adults). Retrieved 16 Nov 2026.
How many people in India are 65 or older?
7.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
How much research is published on Smoking Cessation Products?
PubMed lists 9,665 papers on Smoking Cessation Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in India

See all

Related on smoking and respiratory

See the topic